-
D-N-Acetylgalactosamine: Practical Protocol Guide
2026-09-10
D-N-Acetylgalactosamine (SKU B7904) provides a defined, water-soluble carbohydrate-related reagent for controlled glycoprotein and brain heteropolysaccharide workflows. It is suitable for freshly prepared aqueous or DMSO solutions, but not for ethanol-based procedures or long-term storage of prepared solutions.
-
Adefovir: From Polymerase Readout to OAT1
2026-09-10
Adefovir (GS-0393) is more than an HBV polymerase inhibitor: it connects antiviral pharmacology with renal OAT1 transport biology. This article explains how to design assays that distinguish molecular potency, cellular exposure, and transporter-mediated clearance.
-
NLRP3 Astrocyte Remodeling in Morphine Tolerance
2026-09-09
Yuan et al. link spinal NLRP3 inflammasome activation with a shift toward the neurotoxic A1 astrocyte phenotype during morphine tolerance. Their MCC950 intervention study suggests that inflammasome inhibition can slow tolerance development while normalizing inflammatory and astrocyte-state markers, although the findings remain mechanistic and preclinical.
-
OMV-Displayed mRNA Antigens for Tumor Vaccines
2026-09-09
The reference study developed genetically engineered bacterial outer membrane vesicles that rapidly capture sequence-labeled mRNA antigens and promote their delivery, endosomal escape, and cross-presentation in dendritic cells. This plug-and-display system produced antitumor activity and immune memory in mouse models, while also highlighting manufacturing and translational questions for personalized mRNA vaccination.
-
Protease Inhibitor Cocktail for DFCP1–ATGL Assays
2026-09-08
A practical workflow for preserving DFCP1, ATGL, and lipid-droplet complexes during starvation and extraction studies. Learn how to use an EDTA-containing Protease Inhibitor Cocktail for Western blotting, Co-IP, tissue lysates, imaging support, and kinase assays while avoiding chelation-related artifacts.
-
Mavorixafor Hydrochloride: Assay Strategy
2026-09-08
AMD-070 hydrochloride is more than a CXCR4 antagonist: it enables genotype-aware studies of migration, signaling, and disease-context biology. This guide connects WM-focused evidence with practical assays, handling decisions, and carefully bounded anti-HIV research applications.
-
GSK3 Inhibition Controls M. tuberculosis Infection
2026-09-07
The 2024 iScience study identifies glycogen synthase kinase 3 as a host pathway that supports intracellular Mycobacterium tuberculosis growth. By combining kinase screening, genetic perturbation, pharmacology, and phospho-proteomics, the work establishes GSK3 inhibition as a mechanistically distinct host-directed strategy for tuberculosis research.
-
Alternariol and the Fibrosis Translational Frontier
2026-09-05
A mechanistic and strategic guide to using Alternariol as a defined tool for mycotoxin research, hepatic stellate cell biology, metabolism studies, and translational food-safety investigation.
-
AMG 9810: TRPV1 Strategy for Translational Pain Research
2026-09-05
AMG 9810 is more than a selective TRPV1 antagonist: it is a practical tool for separating receptor-level sensory signaling from the metabolic and redox context that shapes experimental phenotypes. This thought-leadership article connects TRPV1 pharmacology with recent findings on the AMPK–SQSTM1/p62 stress-adaptation loop, while clearly distinguishing established evidence from forward-looking hypotheses. It provides a translational workflow for calcium imaging, CGRP measurement, and stress-state stratification in pain mechanism research.
-
Celastrol, CAV-1, and Mitophagy in Liver Cancer
2026-09-04
A 2026 Phytomedicine study identifies the CAV-1/SCP2 axis as a regulatory link between cholesterol trafficking, mitochondrial stress, and mitophagy in liver cancer. Its combined imaging, molecular, and xenograft evidence suggests that organelle-specific cholesterol redistribution may provide a distinct route to suppress tumor growth, while also defining important validation steps for future translational work.
-
Sodium Picosulfate in Gut–Brain Research
2026-09-04
Sodium Picosulfate provides a controllable way to study intestinal transit, secretion, and electrolyte shifts in translational gastrointestinal models. When paired with fecal profiling and regional neuroinflammation imaging, it can help separate gut-motility effects from gut–liver–brain biology without overstating causality.
-
Taihangia rupestris: DPPH and UPLC-MS/MS Insights
2026-09-03
A 2026 RSC Advances study combined UPLC-MS/MS, multivariate analysis, antioxidant assays, α-glucosidase inhibition, affinity screening, and molecular docking to compare wild and cultivated Taihangia rupestris leaves. Foothill cultivation produced the strongest chemical and functional profile, suggesting that carefully controlled cultivation may support conservation while preserving bioactive potential.
-
Elobixibat hydrate: IBAT Workflows and Use Cases
2026-09-03
Elobixibat hydrate enables research workflows that connect ileal bile acid transport with colonic motility, TGR5 signaling, and metabolic readouts. This practical guide covers concentration handling, translational assay design, bowel-preparation research, and troubleshooting without confusing local gut activity with systemic pharmacology.
-
EMD638683: From SGK1 to Vascular Stiffness
2026-09-02
EMD638683 offers a mechanism-first route to investigate how SGK signaling links sodium handling, actin remodeling, vascular stiffness, and tumor-cell survival. This thought-leadership guide interprets the endothelial SGK1 evidence, defines practical validation workflows, and clarifies where an SGK1 inhibitor is informative for cardiovascular and cancer research.
-
Beyond MAPK: SCH772984 HCl in Translational Biology
2026-09-02
A thought-leadership perspective on using SCH772984 HCl as an ERK1/2 inhibitor to connect pathway reactivation, tumor resistance, melanoma biology, and emerging APEX2–TERT research while preserving rigorous translational boundaries.